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Abstract
Currently HIV infected men and women are living longer quality lives. This
phenomenon is raising more and more ethical questions concerning ability to
reproduce offspring. HIV infected women frequently ask health care providers
about the safety and risks of becoming pregnant. HIV infected women also face the
challenges of fertility more frequently and seek assisted reproductive technologies.
Each case raises many ethical questions. The case study discussed in this paper
illustrates the ethical issues raised by knowingly risking the birth of a child, as well
as the health of the woman infected with HIV. The paper also offers a more
balanced approach to enable nurses to understand the issues.

Keywords:
Ethical Principles, Assisted Reproduction, HIV-infected Women, Infertility, Ethical Issues

1

The Ethics of Assisted Reproduction Technologies

The Ethics of Assisted Reproduction Technologies
and the HIV Infected Woman
INTRODUCTION
In the United States, 25 percent of all newly acquired immune deficiency syndrome
(AIDS) cases and 35 percent of human immunodeficiency virus (HIV-1) infections occur
in women (CDC, 2001). Women represent the subgroup with the fastest rate of increase
in HIV infection. The majority of these women are of reproductive age, and many of the
risk factors linked to HIV infection (e.g., unsafe sexual activities) may also predispose
women to infertility (Lindegreen, et al., 1999). Since the early years of the HIV epidemic,
the treatment of infertility in HIV-infected women, as well as couples, has remained
highly controversial. The possibility of mother-to-child transmission of HIV and the
likelihood that the mother will die before her child reaches complete independence are
among the issues faced by health care providers treating HIV positive women seeking
artificial reproductive technologies (ART). The use of highly active antiretroviral therapy
and protocols for the reduction of the risk of mother-to-child transmission of HIV evoke
continued critical ethical considerations in the treatment of infertility in women with HIV
infection.
The risk of HIV transmission to offspring can be greatly reduced but not eliminated. This
risk raises ethical issues concerning the scope of freedom to reproduce (autonomy),
what can be considered harm (fetal beneficence) sufficient to justify restricting that
freedom, and the responsibilities (duty) of health care professionals faced with a request
to provide ART services to HIV infected patients. The following is a case study to
illustrate the ethical issues raised by knowingly risking the birth of a child with HIV.
Case Information
The patient is a 26-year-old female with HIV infection. She presented to an advanced
practice nurse with request for assistance with infertility treatment. She reported that
she has been having unprotected intercourse for 18 months without achieving
pregnancy with her significant other, also HIV positive. She also reported strict
adherence to her antiretroviral regimen as well as undetectable viral status for herself
(<50 copies) and near undetectable viral status for her significant other (598 copies).
Past Medical History
The patient tested positive for HIV in 1999 at a local health fair offering free testing. Her
CD4 count was 279/mm3 with a viral load of greater than 750,000 copies. She started
taking zidovudine/ lamivudine (Combivir, GlaxoSmith Klein), one tablet twice daily and
nelfinavir (Viracept, Agouron) 250mg, five tablets twice daily, to treat her HIV disease.
She had an excellent virologic response to her antiretroviral regimen that resulted in a
CD4 count of 525/mm3 and a viral load that was less than 400 copies within eight
weeks. Menses are stated as regular by the patient. No other significant medical history
was noted. No surgical history was noted.
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Family History
Mother: Alive and well; hyperlipidemia, surgical menopause at age 51, G 4P4004
Father: Alive and well; HTN, CHF
Siblings: Alive and well; no known comorbidities
Social History
The patient has been employed as a sales clerk in a local retail store for three years.
Her significant other works as a car dealer. They live together in a three-bedroom
house. There is no history of injection drug use or tobacco abuse. The patient drinks
alcohol on rare social occasions.
Sexual History
G1P1001 , menarche: age 13. First intercourse: age 15. Number of lifetime partners: 20+.
Denies history of anal intercourse. Positive for history of rape at age 15 by older, known
family member. Last menstrual period: 15 days ago, regular.
Current Medications
No Known Drug Allergies
Zidovudine/ lamivudine (Combivir): one tablet twice daily
Nelfinavir (Viracept): 250mg, five tablets twice daily
Multivitamin one tablet daily
Laboratory values at Initial Office Visit
HIV viral load: <50 copies/ ml
CD4+: 789/mm3
Assessment
S: 26 yo HIV+ female desiring ART
O: WNL
A: Tubal infertility
P: Should the patient be offered ART?
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The Issues
A consensus is emerging that ART should be offered to some couples in which one or
both partners are infected with HIV. More ethical and scientific literature states there is
now an ethical obligation to provide ART to such couples, consistent with respect for
both autonomy and beneficence (Anderson, 1999; Minkoff & Santoro, 2000). Those who
support providing these services to this population cite three major reasons. First,
therapeutic improvements in the management of HIV infection have enhanced both
quality and length of life for HIV-positive individuals. Second, advances in prenatal
therapy have substantially reduced the risk of mother-to-infant HIV transmission. Third,
current ART methods will reduce transmission of HIV from an infected partner to an
uninfected partner (Anderson; 1999, Ethics Committee of the American Society for
Reproductive Medicine, 2002; Minkoff & Santoro, 2000).
Those who oppose offering ART to HIV-infected couples cite two major objections:
uncertain long-term parental prognosis, and the continuing risk of maternal-to-fetal HIV
transmission. The ethical underpinning of this opposition is that the best interest of the
child to be born to a parent who may not be available for continuing childrearing is at
stake. In addition, the risk of maternal to child transmission places the child at risk of
acquiring a highly debilitating illness (Dubler & Levine, 1990).
Health care providers should keep in mind that an ethical debate supports two
seemingly correct answers. Clinical ethics provide a structured approach for identifying,
analyzing, and resolving both sides of the issue. The practice of good clinical health
care requires a working knowledge about ethical issues, such as confidentiality, patient
rights, truth telling and informed consent. It also is necessary that while philosophically
studying the morality of the debate each of the issues, problems, and judgments are
open for individual interpretation. This individual interpretation imposes increased
difficulty in removing one’s own moral issues from the debate and focusing on the
debates ethical attributes. Clinical ethics relies on the certainty that, even when
perplexity is great and emotions strong, health care providers, patients and their families
can work constructively to identify, analyze, and resolve many of the ethical problems
that appear in the clinic arena.
Practitioner Responsibilities
Prima facie duty is defined as a conditional duty always acted on unless it conflicts on a
particular occasion with a more stringent duty (Arras, 1999). Today a health care
provider’s ethical duty is to accept a patient or to continue to care for a person who is
HIV-positive and to not discriminate against those who choose to reproduce, even
though it may be against the provider’s moral standards (Annas, 1998). If the provider
believes that in view of residual risk to the child and the mothers uncertain future, he or
she does not wish to help the patient, his/her duty is to direct them to another provider
who may be able to help them. The duty of the health care provider who counsels HIV
positive patients is to fully inform them of the potential risks of transmission and

4

The Ethics of Assisted Reproduction Technologies

recommend the safest procedures for conception and delivery. This counseling includes
discussion concerning administration of antiretroviral drugs to the HIV positive woman
during the second and third trimesters of her pregnancy and to her baby during its first
six weeks of life to limit the risk of mother-to-child HIV transmission to <1% (DHHS,
2003). Couples should also be advised that the absolute safest courses to consider are
adoption, child-free living, or (if the male is HIV-positive) donor sperm.
Health care providers also have a duty to fully inform couples about risks incurred by
the child such as vertical transmission of HIV from the mother, potential drug toxicities,
unknown effects of drugs and/ or virus on long-term development of the child (Ethics
Committee, 2002). Finally, attention must be drawn to uncertainties regarding the
mother’s future health due to her HIV infection. The aim is to provide full, clear and
factual information enabling the couple to make an enlightened and autonomous
decision.
Ethical Principles
Autonomy derives from the Greek autos (self) and nomon (rule or governance) and
literally means self-rule (Pickett, 2001). In health care practice, the principle of
autonomy implies personal rule of the self that is free both from controlling interferences
by others and from personal limitations that prevent meaningful choice, such as
inadequate understanding (Beauchamp & Childress, 2001). Respect for a patient’s
autonomy acknowledges a person’s right to hold views, to make choices, and to take
actions based on personal values and beliefs. Couples who are at risk for having other
potentially life-threatening conditions that may affect them physically by conceiving or
affect the outcome of the unborn child are not as scrutinized as HIV positive individuals.
Treatment for ART is offered to other individuals with other illnesses such as cancer or
heart disease or brittle diabetics. People who have genetic illnesses or who are at high
risk for producing offspring with genetic illnesses are not condemned for the choice of
parenthood. The right for reproductive choice comes from the principle of autonomy,
whereas bringing about the birth of a child with a genetic disease has been considered
as causing harm by some (Macer, 1990). Couples do not forego parenthood only
because they are at high risk for producing a child that will have sickle cell disease,
Down Syndrome, or cystic fibrosis, for example. Couples who conceive naturally do not
have to justify their desire to have children. Maternal age is another risk factor that
places offspring at risk although in most cases is overlooked by society. Being HIV
positive does not mean that having an ill child is any worse than couples having an ill
child from cystic fibrosis, sickle cell, or Down Syndrome. Unless however, the health
care provider or society is allowing morality to overcome ethics. Autonomy provides a
strong moral foundation for informed consent, in which a patient, fully informed about
her medical condition and the available therapies, freely chooses to be a willing
participant in any treatment or non-treatment (Mappes, 2001). Respect for patient
autonomy, like all ethical principles, cannot be regarded as absolute and may at times
be in conflict with other principles or other moral considerations. This health care
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providers regards must allow for the patients autonomy and decision to conceive a child
and reach a balance with fetal beneficence.
Beneficence, which means doing or producing good, is the obligation to promote the
well-being of others (Pickett, 2001). In this case, the fetus must be considered in regard
to the ethical principle of beneficence. Although the risk of vertical transmission of HIV
infection from mother-to-child can be reduced in many ways, the risk cannot be
completely avoided. Health care providers who evaluate the ethics of assisting such
patients to have children must address the question of whether offspring born with HIV
are harmed despite the preventive steps taken. The health care providers and parents
must consider the child may be born with HIV. In situations in which a child could be
born with a serious disease, one can argue that individuals are not acting unethically in
proceeding with reproduction if all reasonable precautions are taken to prevent disease
transmission. Similarly, one can argue that health care providers are not acting
unethically if all reasonable precautions to limit the risk of transmission of HIV are taken.
However, health care providers cannot ethically proceed with ART if the facilities lack
the clinical and laboratory resources needed to effectively care for HIV-positive couples
that wish to have a child (Ethics Committee, 2002). In such instances, the health care
provider should refer couples to a center that has these resources.
Finally, justice is the principle of rendering what is due to others (Pickett, 2001). Justice
is the most complex of the ethical principles to be considered because justice deals with
the health care provider’s obligation to render to a patient what is owed and with the
provider’s role in the allocation of limited medical resources in the community. Justice is
the obligation to treat equally those who are alike or similar according to whatever
criteria are selected. The issue of justice raised in this case is similar in some respects
to those in couples who know they are carriers of an autosomal recessive disease, such
as sickle cell anemia, Tay-Sachs disease or cystic fibrosis. The risk of transmitting an
autosomal recessive genetic disease cannot be reduced below 25 percent, whereas the
risk of HIV transmission can be reduced to as low as <1 percent (Lindegreen, et al.,
1999). Health care providers who are willing to provide ART to couples whose offspring
are irreducibly at risk for a serious genetic disease should find it ethically acceptable to
treat HIV-positive individuals who are willing to take reasonable steps to minimize the
risks of transmission.
Case Review
In this case, the advanced practice nurse examined her own moral regards and chose
to be guided by ethical principles, thus choosing to assist the patient and continue
further care as part of her duty. Information was provided to completely inform the
patient of all risks of pregnancy and HIV, as well as all options of ART. Time was
offered to the patient to allow for autonomy in decision-making. This patient reported
complete adherence to taking her antiretroviral medication regimen. Her laboratory
results indicated viral control (VL < 50 copies), as well as a healthy immune system
(CD4+ 789/mm3). These values infer minimal (<1percent) risk of viral transmission from
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mother-to-child as well as decreased risk for infection to the mother. Fortunately, a
balance of patient autonomy and fetal beneficence could be established in this case.
Based on the information provided to reduce viral transmission risks and allow for the
promotion of fetal beneficence, as well as mother beneficence, the patient was allowed
and capable of being autonomous in the decision making process of her pregnancy and
care. The patient was then referred to an obstetrician who specializes in assisted
reproduction.
Conclusion
Requests for ART by HIV-infected couples will most probably increase in the future. The
consortium of infected individuals with stable illness and with or without infertility is
growing. These individuals are becoming aware of the low risk of maternal-to-infant HIV
transmission with appropriate treatment and are desirous of attempting to achieve
pregnancy.
Assisted reproductive technologies should not be denied to HIV-infected individuals
solely on the basis of their positive serostatus. Offering these technologies to infected
individuals is consistent with balancing respect for autonomy with fetal beneficence.
This field is an emerging one and is changing rapidly. Patients should be cared for by
providers who have current knowledge and expertise in this field. For this reason,
nurses as well as other health care providers, need to educate themselves with the
ethical considerations, the technologies involved, and the accompanying knowledge
base needed to advocate for these patients.
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